International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy

Abstract

LVI is strongly associated with clinical outcome in node-negative patients treated with RC. The assessment of LVI might help to identify patients who could benefit from adjuvant therapy after RC. After confirmation in different populations, LVI should be included in the staging of UCB.